Mohamed Ayman El-Zahabi

9PUBLICATIONS
28CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and designBiologically active moleculesGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 28, 2026
Insights into the Design of MYC-Targeting Proteolysis Targeting Chimeras (PROTACs).

Abdallah M Alfayomy, Sven Hagemann, Matthias Schmidt

|Jul 04, 2025
Synthesis, antiproliferative evaluation and in silico studies of new quinazoline derivatives as VEGFR-2 inhibitors.

Abdelsalam Mohamed Abdelsalam Ouf, Adel A Marzouk, Montaser Sh A Shaykoon

|Nov 14, 2024
Design and synthesis of new nicotinamides as immunomodulatory VEGFR-2 inhibitors and apoptosis inducers.

Reda G Yousef, Ibrahim H Eissa, Hazem Elkady

|Nov 14, 2024
Discovery of New Immunomodulatory Anticancer Thalidomide Analogs: Design, Synthesis, Biological Evaluation and In Silico Studies.

Abdallah E Abdallah, Ibrahim H Eissa, Ahmed B M Mehany

|Nov 12, 2024
New immunomodulatory anticancer quinazolinone-based thalidomide analogs: design, synthesis and biological evaluation.

Maged Mohammed Saleh Al Ward, Abdallah E Abdallah, Mohamed F Zayed

|Dec 15, 2023
New nicotinamide derivatives as potential anticancer agents targeting VEGFR-2: design, synthesis, in vitro, and in silico studies.

Reda G Yousef, Ibrahim H Eissa, Hazem Elkady

Pageof 2

Frequent Collaborators

4 joint publications

Hazem Elkady

2 joint publications

Khaled El-Adl

2 joint publications

Abdallah E Abdallah

2 joint publications

Ibrahim H Eissa